-
Product Insights
Westlich der Ems Field, Germany
Westlich der Ems upstream field is located in Lower Saxony, Germany. The upstream field is owned by Wintershall Dea AG. It is operated by Wintershall Dea AG. The project started its operations in 2003. Westlich der Ems Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and capital and operating costs....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EM-113 in Autism Spectrum Disorder (ASD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.EM-113 in Autism Spectrum Disorder (ASD)Drug Details:EM-113 is under development for the treatment of autism spectrum...
-
Product Insights
Apeejay – EM Bypass Park Hotel – West Bengal
Equip yourself with the essential tools needed to make informed and profitable decisions with our Apeejay - EM Bypass Park Hotel - West Bengal report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
LIC – EM Bypass Commercial Complex – West Bengal
Equip yourself with the essential tools needed to make informed and profitable decisions with our LIC - EM Bypass Commercial Complex - West Bengal report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
CORO/ CRD/ EME – Mako Gas Field Development – Riau Islands
Equip yourself with the essential tools needed to make informed and profitable decisions with our CORO/ CRD/ EME - Mako Gas Field Development - Riau Islands report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Sichuan EM Tech – Mianyang Functional Membrane Material Production Base – Sichuan
Equip yourself with the essential tools needed to make informed and profitable decisions with our Sichuan EM Tech - Mianyang Functional Membrane Material Production Base - Sichuan report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
MoPWT Cambodia – Lvea Em district to National Road 1 Road Development – Kandal
Equip yourself with the essential tools needed to make informed and profitable decisions with our MoPWT Cambodia - Lvea Em district to National Road 1 Road Development - Kandal report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
Dare County – Kill Devil Hills Fire and EMS Station Development – North Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our Dare County - Kill Devil Hills Fire and EMS Station Development - North Carolina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Company Profile
EMS SA – Company Profile
EMS SA (EMS), a subsidiary of Grupo NC, is a pharmaceutical company that focuses on the development of products for the improvement of the health and well-being of the population. The company operates in the segments of medical prescription, generics, branded pharmaceuticals, manufacturing products, OTC, and hospitals. Its major product portfolio includes drugs in the therapeutic areas of anti-inflammatories, analgesics, antihypertensives, anthelmintics, antidiabetics, antibiotics, anti-ulcers, topical corticosteroids, and anti-flu. EMS has production units in Sao Bernardo do Campo, Jaguariuna and...
Add to Basket -
Product Insights
TAKAFUL-EM – JVC: Residential Building (JVC10CMRH009) – Dubai
Equip yourself with the essential tools needed to make informed and profitable decisions with our TAKAFUL-EM - JVC: Residential Building (JVC10CMRH009) - Dubai report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CD-388 in Influenzavirus B Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Influenzavirus B Infections Drug Details:CD-388 is under development for the treatment and prevention of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CD-388 in Pandemic Influenza
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Pandemic InfluenzaDrug Details:CD-388 is under development for the treatment and prevention of influenzavirus A,...
-
Company Profile
Ems-Chemie Holding AG – Company Profile
Ems-Chemie Holding AG (Ems-Chemie), a subsidiary of Emesta Holding AG, is a chemical company. It manufactures and markets polymers and specialty chemicals. The company’s products range includes bonding products, polyamides, damping systems, sealants, and coating products. Ems-Chemie also offers thermoplastic material, technical fibers, technical staple fiber, hot-melt adhesives, and epoxy-resins. It also provides reactive diluents, crosslinkers, fibers, ignitors, adhesion promoters, and granules. The company serves automotive, electro and electronic, industry and consumer goods, optic and packaging industries. It offers products...
Add to Basket -
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CD-388 in Seasonal Influenza
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Seasonal Influenza Drug Details:CD-388 is under development for the treatment and prevention of influenzavirus...
-
Company Insights
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AUTO-8 in Refractory Multiple Myeloma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AUTO-8 in Refractory Multiple Myeloma Drug Details:AUTO-8 is under development for the treatment of relapsed and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Spebrutinib Besylate in Follicular Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Spebrutinib Besylate in Follicular Lymphoma Drug Details:Spebrutinib besylate (CC-292, AVL-292) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRT-1419 in Head And Neck Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PRT-1419 in Head And Neck CancerDrug Details:PRT-1419 is under development for the treatment of solid tumors,...
-
Product Insights
NewInnovation in consumer: Plant based antioxidants
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the consumer industry’s Natural complex preservatives innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience...